Common Stock, Shares, Outstanding of ENvue Medical, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ENvue Medical, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • ENvue Medical, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,011,086, a 64% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ENvue Medical, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,011,086 -1,773,267 -64% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 787,359 -1,996,994 -72% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 734,025 -2,050,328 -74% 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 37,894 -148,134 -80% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 2,784,353 +942,022 +51% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 2,784,353 +1,122,023 +67% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 2,784,353 +1,122,023 +67% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 186,028 -1,455,118 -89% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 1,842,331 -26,155,462 -93% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 1,662,330 -26,335,463 -94% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 1,662,330 -26,335,463 -94% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 1,641,146 +241,256 +17% 31 Dec 2022 10-K 08 Apr 2024 2023 FY
Q3 2022 27,997,793 +819,667 +3% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 27,997,793 +3,888,159 +16% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 27,997,793 +3,888,158 +16% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 1,399,890 -19,846,633 -93% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 27,178,126 +14,684,473 +118% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 24,109,634 +19,795,870 +459% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 24,109,635 +19,795,871 +459% 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 21,246,523 +17,042,759 +405% 31 Dec 2020 10-K 15 Apr 2022 2021 FY
Q3 2020 12,493,653 +8,063,689 +182% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 4,313,764 +173,800 +4.2% 30 Jun 2020 10-Q/A 24 Aug 2020 2020 Q2
Q1 2020 4,313,764 +237,242 +5.8% 31 Mar 2020 10-Q 06 Jul 2020 2020 Q1
Q4 2019 4,203,764 +402,242 +11% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 4,429,964 +462,904 +12% 30 Sep 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 4,139,964 +182,011 +4.6% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 4,076,522 +140,657 +3.6% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 3,801,522 -134,343 -3.4% 31 Dec 2018 10-K 20 May 2020 2019 FY
Q3 2018 3,967,060 +1,334,350 +51% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 3,957,953 +1,325,243 +50% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 3,935,865 +1,303,155 +49% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 3,935,865 +1,303,155 +49% 31 Dec 2017 10-K 13 May 2019 2018 FY
Q3 2017 2,632,710 0 0% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 2,632,710 +9,000 +0.34% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 2,632,710 +9,000 +0.34% 31 Mar 2017 10-Q/A 26 Jul 2017 2017 Q1
Q4 2016 2,632,710 +21,382 +0.82% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 2,632,710 +21,382 +0.82% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 2,623,710 +12,382 +0.47% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 2,623,710 +2,243,463 +590% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 2,611,328 +2,447,748 +1496% 31 Dec 2015 10-K/A 26 Jul 2017 2016 FY
Q3 2015 2,611,328 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 2,611,328 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 380,247 31 Mar 2015 10-Q 10 Jun 2015 2015 Q1
Q4 2014 163,580 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.